Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...

Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.

WHO declares Georgia malaria-free, but why does malaria persist despite vaccine challenges and historical breakthroughs in ...

Cell-engineering company, MaxCyte, Inc., announced it will acquire SeQure Dx, which focuses on editing assessment services for cell and gene therapies, for $4.5 million. The all-cash deal includes ...

Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been extensively exploited as a preventive vaccine. Despite the global ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of ...

Results show improved functional outcomes for people with Duchenne muscular dystrophy who are ambulatory. Elevidys, which is ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

The Zika virus modifies the chemical composition of human skin, making individuals more attractive to mosquitoes. These ...